CGM Use in Children With Type 2 Diabetes (IMPaCT2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04721158|
Recruitment Status : Recruiting
First Posted : January 22, 2021
Last Update Posted : January 22, 2021
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes Hyperglycemia Due to Type 2 Diabetes Mellitus||Device: Continuous glucose monitor||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||IMPlementation of Continuous Glucose Monitoring in Children With Type 2 Diabetes|
|Actual Study Start Date :||January 17, 2021|
|Estimated Primary Completion Date :||December 30, 2021|
|Estimated Study Completion Date :||December 30, 2021|
Children with type 2 diabetes will wear a continuous glucose monitor for 10 days.
Device: Continuous glucose monitor
Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.
Other Name: Dexcom G6 CGM
- Change in Time in range glucose control [ Time Frame: Baseline and 10 days ]Change in time in range glucose control from baseline to 10 days.
- Change in Hemoglobin A1c [ Time Frame: Baseline, 3 months and 6 months ]Changes in HbA1c from baseline to follow-up.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04721158
|Contact: Risa M Wolf, MDemail@example.com|
|Contact: Sheela N Magge, MD, MSCEfirstname.lastname@example.org|
|United States, Maryland|
|Johns Hopkins Pediatric Diabetes Center||Recruiting|
|Baltimore, Maryland, United States, 21287|
|Contact: Risa M Wolf, MD 410-955-6463 email@example.com|
|Principal Investigator:||Risa M Wolf, MD||Johns Hopkins School of Medicine|